Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 490 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ophthalmic Surgery Clear all

Conditions: Skull Base Neoplasms, Skull Neoplasms, Bone Neoplasm, Neoplasms, Bone Diseases, Musculoskeletal Disease
Interventions: near-infrared light nasal endoscope used with ICG; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cataract, Astigmatism
Interventions: Conventional, Refractive Cataract Suite (Verion + ORA); Device
Lead sponsor: Carolina Eyecare Physicians, LLC; Other
Eligibility: 50 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Mt. Pleasant, South Carolina

Conditions: Pars Plana Vitrectomy, Scleral Buckling, Surgical Outcomes, Infection Prophylaxis
Interventions: Not listed
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Glaucoma, Open Angle, MIGS, Minimally Invasive Glaucoma Surgery, Canaloplasty, Intraocular Pressure (IOP), Cataract Surgery, Surgical Technique, Minimally Invasive Surgical Technique, Glaucoma
Interventions: Retrospective chart review; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Cataract
Interventions: Clareon PanOptix Pro IOL; Device
Lead sponsor: Juliette Eye Institute Research Center; Other
Eligibility: 45 Years and older
Enrollment: 40 participants
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Inflammation
Interventions: Difluprednate, Placebo; Drug · Other
Lead sponsor: Sirion Therapeutics, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Cataract
Interventions: Loteprednol etabonate, Prednisolones acetate; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: Up to 11 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Inflammation, Pain, Cataract
Interventions: Mapracorat, Vehicle; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Open-Angle Glaucoma
Interventions: Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis; Procedure
Lead sponsor: Barnet Dulaney Perkins Eye Centers; Network
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Intraocular Melanoma, Melanoma (Skin)
Interventions: incomplete Freund's adjuvant, multi-epitope melanoma peptide vaccine, sargramostim; Biological
Lead sponsor: University of Virginia; Other
Eligibility: 12 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Cataract, Cataract (Post-operative Cataract Surgery Follow-up)
Interventions: Music and Guided Imagery, Control, Music Only; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Eyelid Diseases, Ptosis, Eyelid, Blepharoptosis, Dermatochalasis, Ectropion, Entropion, Eyelid Tumor, Skin Cancer, Eyelid, Floppy Eyelid Syndrome
Interventions: Telemedicine follow-up; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cataract
Interventions: Alcon Vivity toric intra ocular lens; Device
Lead sponsor: Kevin Barber; Other
Eligibility: 45 Years and older
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: DeLand, Florida

Conditions: Dry Eye
Interventions: Not listed
Lead sponsor: Innovative Medical; Industry
Eligibility: 55 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Glaucoma, Glaucoma Following Surgery
Interventions: Digital microscope integrated with intraoperative OCT (Zeiss Artevo 800, Carl Zeiss Meditec AG), Spectralis Anterior-segment OCT (AS-OCT) (Heidelberg Engineering); Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Incipient Cataract, Senile Nuclear Sclerosis
Interventions: Laser-assisted cataract surgery., Traditional manual phacoemulsification; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 99 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cataract Surgery, Eye Care, Glasses, Primary Eye Care, Vision Center, Eyecare Visits
Interventions: Establishment of a vision center; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 150,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Kidney Diseases, Eye Diseases, Cardiac Disease, Surgery, Low Back Pain
Interventions: Multicomponent Physician Performance Peer-Comparison Feedback Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 5,000,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Open-angle Glaucoma (OAG)
Interventions: CycloPen Micro-Interventional Cyclodialysis System, CycloPen Micro-Interventional Cyclodialysis System Post Cataract; Procedure
Lead sponsor: Iantrek, Inc.; Industry
Eligibility: Not listed
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 10
States / cities: Newport Beach, California • Cape Coral, Florida • DeLand, Florida + 7 more

Conditions: Cataract
Interventions: Survey; Other
Lead sponsor: MDbackline, LLC; Other
Eligibility: 1 Year to 99 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Laguna Hills, California

Conditions: Aphakia, Presbyopia
Interventions: Clareon PanOptix Pro/Pro Toric Trifocal IOL, Phacoemulsification; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 22 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Torrance, California • Kansas City, Missouri • Mt. Pleasant, South Carolina + 2 more

Conditions: Glaucoma
Interventions: Rho-Kinase Inhibitor (AR-12286); Drug
Lead sponsor: New York Glaucoma Research Institute; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Ocular Inflammation and Pain
Interventions: OTX-DP (Dexamethasone punctum plug), Placebo Vehicle Punctum Plug; Drug
Lead sponsor: Ocular Therapeutix, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Hoffman Estates, Illinois

Conditions: Dry Eye Disease, Meibomian Gland Dysfunction, Cataract Senile, Dry Eye Syndromes
Interventions: Systane iLux Treatment; Device
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base Surgery

Conventional Surgery vs. Verion/VerifEye

Necessity of Post-operative Eye Drops

Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty

Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)

Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Randomized Controlled Trial of the STEIN Protocol: A Neuroplastic Pain Education and Guided Breathing Intervention During Awake Cataract Surgery

Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery

Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.

Prospective Health Assessment of Cataract Patients' Ocular Surface

Anterior-segment OCT (AS-OCT) and Intraoperative OCT (iOCT) for Trans- Conjunctival Needle Revision (TCNR)

Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery

Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes

Smarter Care Virginia, Examining Low-Value Care in Virginia

5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

Satisfaction With Multifocal vs Accommodating Lens Implants 2 Years After Surgery

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention

Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction